Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongrentang Angong Niuhuang Wan is a classic Traditional Chinese Medicine (TCM) formula manufactured by Beijing Tongrentang. It is primarily indicated for the treatment of acute cerebrovascular diseases, including stroke, encephalitis, and meningitis, particularly when accompanied by high fever and loss of consciousness. The formula consists of eleven ingredients, including natural cow bile (Calculus Bovis), water buffalo horn, and musk. In the context of traumatic brain injury (TBI), it is utilized to promote the recovery of neurological and cognitive functions postoperatively. The drug is believed to exert its effects by reducing neuroinflammation, protecting the blood-brain barrier, and modulating neurotransmitter levels to facilitate the restoration of consciousness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongrentang Angong Niuhuang Wan.